In a research report released yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform on La Jolla Pharmaceutical (LJPC) with a $45 price target, …
In a research note issued Thursday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on La Jolla Pharmaceutical Co. (LJPC) and a price target of $34.
